Publications by authors named "Haolun Shi"

Claim this Profile
I
Identification of Regions of Interest in Neuroimaging Data With Irregular Boundary Based on Semiparametric Transformation Models and Interval-Censored Outcomes.
Chun Yin Lee, Haolun Shi, Da Ma, Mirza Faisal Beg, Jiguo Cao

Stat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penalized functional regression using R package PFLR.
Rob Cameron, Tianyu Guan, Haolun Shi, Zhenhua Lin

J Appl Stat· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings (CanTreatCOVID): protocol for a randomised controlled adaptive platform trial of treatments for acute SARS-CoV-2 infection in community settings.
Banafshe Hosseini, Amanda Condon, Bruno R da Costa, Peter Daley, Michelle Greiver, Haolun Shi

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Aggregate Data Adjustment Method for Transportability Analysis Utilizing Summary-Level Data From the Target Population.
Yichen Yan, Quang Vuong, Rebecca K Metcalfe, Tianyu Guan, Haolun Shi

Pharm Stat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drift Parameter Based Sample Size Determination in Multi-Stage Bayesian Randomized Clinical Trials.
Yueyang Han, Haolun Shi, Jiguo Cao, Ruitao Lin

Pharm Stat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Latent-Class Model for Time-To-Event Outcomes and High-Dimensional Imaging Data.
Jiahui Feng, Haolun Shi, Ma Da, Mirza Faisal Beg, Jiguo Cao

Stat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Generalized Phase I/II Dose Optimization Trial Design With Multi-Categorical and Multi-Graded Outcomes.
Yichen Yan, Ruitao Lin, Tianyu Guan, Haolun Shi, Xiaolei Lin

Stat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supervised Functional Principal Component Analysis Under the Mixture Cure Rate Model: An Application to Alzheimer'S Disease.
Jiahui Feng, Haolun Shi, Da Ma, Mirza Faisal Beg, Jiguo Cao

Stat Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative review of novel model-assisted designs for phase I/II clinical trials.
Haolun Shi, Ruitao Lin, Xiaolei Lin

Biom J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early inner plexiform layer thinning and retinal nerve fiber layer thickening in excitotoxic retinal injury using deep learning-assisted optical coherence tomography.
Da Ma, Wenyu Deng, Zain Khera, Thajunnisa A Sajitha, Xinlei Wang, Haolun Shi

Acta Neuropathol Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian single-to-double arm transition design using both short-term and long-term endpoints.
Tianlin Xu, Haolun Shi, Ruitao Lin

Pharm Stat· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
qTPI: A quasi-toxicity probability interval design for phase I trials with multiple-grade toxicities.
Haodong Ling, Haolun Shi, Nan Yuan, Yuan Ji, Xiaolei Lin

Stat Methods Med Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian adaptive model selection design for optimal biological dose finding in phase I/II clinical trials.
Ruitao Lin, Guosheng Yin, Haolun Shi

Biostatistics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALS.
Ruitao Lin, Haolun Shi, Guosheng Yin, Peter F Thall, Ying Yuan

Ann Appl Stat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic prediction with time-dependent marker in survival analysis using supervised functional principal component analysis.
Haolun Shi, Shu Jiang, Jiguo Cao

Stat Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional proportional hazard cure rate model for interval-censored data.
Haolun Shi, Da Ma, Mirza Faisal Beg, Jiguo Cao

Stat Methods Med Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unified Bayesian framework for exact inference of area under the receiver operating characteristic curve.
Ruitao Lin, Kc Gary Chan, Haolun Shi

Stat Methods Med Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jointly modelling multiple transplant outcomes by a competing risk model via functional principal component analysis.
Jianghu James Dong, Haolun Shi, Liangliang Wang, Ying Zhang, Jiguo Cao

J Appl Stat· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trials.
Haolun Shi, Jiguo Cao, Ying Yuan, Ruitao Lin

Stat Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diagnosis of Alzheimer's disease on ADNI data using novel longitudinal score based on functional principal component analysis.
Haolun Shi, Da Ma, Yunlong Nie, Mirza Faisal Beg, Jian Pei

J Med Imaging (Bellingham)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional principal component analysis for longitudinal data with informative dropout.
Haolun Shi, Jianghu Dong, Liangliang Wang, Jiguo Cao

Stat Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
START: single-to-double arm transition design for phase II clinical trials.
Haolun Shi, Teng Zhang, Guosheng Yin

Pharm Stat· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian enhancement two-stage design for single-arm phase II clinical trials with binary and time-to-event endpoints.
Haolun Shi, Guosheng Yin

Biometrics· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landmark cure rate models with time-dependent covariates.
Haolun Shi, Guosheng Yin

Stat Methods Med Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian randomized clinical trials: From fixed to adaptive design.
Guosheng Yin, Chi Kin Lam, Haolun Shi

Contemp Clin Trials· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis